Paper39728024
Rapid Cognitive Deterioration in Progressive Supranuclear Palsy: A 1-Year Follow-Up Study.
Li XY and 13 others. Mov Disord Clin Pract, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Rapid Cognitive Deterioration in Progressive Supranuclear Palsy: A 1-Year Follow-Up Study. Papers, record 39728024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39728024
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Rapid Cognitive Deterioration in Progressive Supranuclear Palsy: A 1-Year Follow-Up Study.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Supranuclear Palsy, Progressive | Major topic |
| Cognitive Dysfunction | Major topic |
| Dementia | Major topic |
| Humans | |
| Male | |
| Female | |
| Aged | |
| Follow-Up Studies | |
| Disease Progression | |
| Neuropsychological Tests | |
| Middle Aged | |
| Aged, 80 and over |
Source PubMed
Grants11
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2018SHZDZX01 | Shanghai Municipal Science and Technology Major Project | PubMed | ||
| 21S31902200 | Shanghai Municipal Science and Technology Major Project | PubMed | ||
| 2023-YN008 | Clinical Research Project Supported by Huashan Hospital, Fudan University | PubMed | ||
| 82171421 | National Natural Science Foundation of China | PubMed | ||
| 91949118 | National Natural Science Foundation of China | PubMed | ||
| 82371266 | National Natural Science Foundation of China | PubMed | ||
| 82171252 | National Natural Science Foundation of China | PubMed | ||
| 81701250 | National Natural Science Foundation of China | PubMed | ||
| 2023ZZ02027 | Shanghai Research Center of Rehabilitation Medicine (Top Priority Research Center of Shanghai) | PubMed | ||
| Pro20211231084249000238 | National Health Commission of People's Republic of China | PubMed | ||
| Z155080000004 | National clinical key specialty construction project of China | PubMed |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28870563 | Executive dysfunction, behavioral changes and quality of life in Chinese patients with progressive supranuclear palsy. | J Neurol Sci | 2017 | https://conductscience.org/library/papers/28870563 | PubMed |
| 2 | 33664663 | Dopaminergic and Metabolic Correlations With Cognitive Domains in Non-demented Parkinson's Disease. | Front Aging Neurosci | 2021 | https://conductscience.org/library/papers/33664663 | PubMed |
| 3 | 31432258 | Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease. | J Neural Transm (Vienna) | 2019 | https://conductscience.org/library/papers/31432258 | PubMed |
| 4 | 29348302 | Tracking brain damage in progressive supranuclear palsy: a longitudinal MRI study. | J Neurol Neurosurg Psychiatry | 2018 | https://conductscience.org/library/papers/29348302 | PubMed |
| 5 | 34541533 | Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants. | Brain Commun | 2021 | https://conductscience.org/library/papers/34541533 | PubMed |
| 6 | 35221987 | The Frontal and Cerebellar Metabolism Related to Cognitive Dysfunction in Multiple System Atrophy. | Front Aging Neurosci | 2022 | https://conductscience.org/library/papers/35221987 | PubMed |
| 7 | 27453032 | Cognitive impairment in progressive supranuclear palsy-Richardson's syndrome is related to white matter damage. | Parkinsonism Relat Disord | 2016 | https://conductscience.org/library/papers/27453032 | PubMed |
| 8 | 28653647 | Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. | Lancet Neurol | 2017 | https://conductscience.org/library/papers/28653647 | PubMed |
| 9 | 20451872 | Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. | Alzheimers Dement | 2010 | https://conductscience.org/library/papers/20451872 | PubMed |
| 10 | 35865639 | The Burden of Progressive Supranuclear Palsy on Patients, Caregivers, and Healthcare Systems by PSP Phenotype: A Cross-Sectional Study. | Front Neurol | 2022 | https://conductscience.org/library/papers/35865639 | PubMed |
| 11 | 24757116 | Cognition in corticobasal syndrome and progressive supranuclear palsy: a review. | Mov Disord | 2014 | https://conductscience.org/library/papers/24757116 | PubMed |
| 12 | 28467028 | Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. | Mov Disord | 2017 | https://conductscience.org/library/papers/28467028 | PubMed |
| 13 | 35350553 | Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based study. | Brain Commun | 2022 | https://conductscience.org/library/papers/35350553 | PubMed |
| 14 | 36627498 | 18F-Florzolotau PET imaging captures the distribution patterns and regional vulnerability of tau pathology in progressive supranuclear palsy. | Eur J Nucl Med Mol Imaging | 2023 | https://conductscience.org/library/papers/36627498 | PubMed |
| 15 | 28881351 | Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy. | Neurodegener Dis | 2017 | https://conductscience.org/library/papers/28881351 | PubMed |
| 16 | 23127882 | Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy. | Arch Clin Neuropsychol | 2013 | https://conductscience.org/library/papers/23127882 | PubMed |
| 17 | 34607584 | A comparison of the Mini-Mental State Examination (MMSE) with the Montreal Cognitive Assessment (MoCA) for mild cognitive impairment screening in Chinese middle-aged and older population: a cross-sectional study. | BMC Psychiatry | 2021 | https://conductscience.org/library/papers/34607584 | PubMed |
| 18 | 37385026 | Neuropathological analysis of cognitive impairment in progressive supranuclear palsy. | J Neurol Sci | 2023 | https://conductscience.org/library/papers/37385026 | PubMed |
| 19 | 30989369 | Motor, cognitive and behavioral differences in MDS PSP phenotypes. | J Neurol | 2019 | https://conductscience.org/library/papers/30989369 | PubMed |
| 20 | 29999569 | Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in 18 F-FDG PET imaging. | Hum Brain Mapp | 2018 | https://conductscience.org/library/papers/29999569 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42852583 | Longitudinal Cognitive Function in Progressive Supranuclear Palsy-A Review of the Evidence for Progression. | Mov Disord Clin Pract | 2026 | https://conductscience.org/library/papers/42852583 | PubMed |
| 41553623 | Dementia in Progressive Supranuclear Palsy: A Narrative Review. | Neurol Ther | 2026 | https://conductscience.org/library/papers/41553623 | PubMed |
| 41051548 | Cross-sectional and longitudinal validation of short and long versions of the progressive supranuclear palsy quality of life scale. | J Neural Transm (Vienna) | 2026 | https://conductscience.org/library/papers/41051548 | PubMed |
| 40820613 | Differences in neuropsychological performance across clinical variants of progressive supranuclear palsy. | J Int Neuropsychol Soc | 2025 | https://conductscience.org/library/papers/40820613 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39728024
GET https://conductscience.org/api/papers/v1/39728024/references?page=2